F portfolio saw a modest increase in value. Check out the significant new stakes and major increases in the portfolio here.

F shows a portfolio value increase to $31.7B. Read more about Jeremy Grantham's holdings and trades for Q1 2025.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $505.0, a high estimate of $529.00 ...

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action on behalf of purchasers of common ...

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual ...

It has been about a month since the last earnings report for Elevance Health (ELV). Shares have lost about 6.3% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Elevance Health Inc. Quarterly cash flow by MarketWatch. View 1ANTM net cash flow, operating cash flow, operating expenses and cash dividends. Elevance Health Inc. Quarterly cash flow by MarketWatch.

ELV BREAKING NEWS: Elevance Health, Inc. Stock Plummets 11% Triggering ... s rate negotiations or in its financial guidance for 2024. The Stock Declines as the Truth is Revealed On July 17 ...

Cruz announces an investigation of Elevance ... HEALTH, INC. (ELV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 17, 2024 ...

We note that Elevance Health, Inc. (NYSE:ELV) does have debt on its balance sheet. But the real question is whether this debt is making the company risky. We've found 21 US stocks that are ...

Down 31.65% from its 52-week closing high of $562.29 on Sept. 3, 2024 --Up 5.06% from its 52-week closing low of $365.83 on Jan. 2, 2025 --Traded as low as $382.90; lowest intraday level since Feb ...